Atlas Trials

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Clinical trial NCT03636763 · UNKNOWN

Trial details

NCT number
NCT03636763
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Study type
OBSERVATIONAL
Bullous Pemphigoid
Start date
2018-09-01
Primary completion
2019-03-01
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.